DOXEPIN HYDROCHLORIDE (DOXEPIN HYDROCHLORIDE) — FDA Approval ANDA071239 (WATSON LABS)
DOXEPIN HYDROCHLORIDE (DOXEPIN HYDROCHLORIDE) — FDA Approval ANDA071239 (WATSON LABS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: DOXEPIN HYDROCHLORIDE; Active ingredients: DOXEPIN HYDROCHLORIDE; Application number: ANDA071239.
| Brand name | DOXEPIN HYDROCHLORIDE |
|---|---|
| Active ingredients | DOXEPIN HYDROCHLORIDE |
| Application number | ANDA071239 |
| Sponsor | WATSON LABS |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19870430 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →